Skip to main content
Fig. 11 | Cancer Nanotechnology

Fig. 11

From: Preparation and characterization of the myricetin-loaded solid lipid nanoparticles decorated with folic acid-bound chitosan and evaluation of its antitumor and anti-angiogenic activities in vitro and in vivo in mice bearing tumor models

Fig. 11

CAM assay. A Stereomicroscopic images of chorioallantoic membrane vessels in treatment with myricetin-SLN-CS-FA compared to control. B–E Significant reduction in mean length and number of blood vessels along with a reduction in embryonic growth factors in myricetin-SLN-CS-FA treated samples. F The effects of myricetin-SLN-CS-FA on VEGF and VEGFR gene expressions (*p < 0.05, **p < 0.01, and ***p < 0.001). The data were presented as mean ± SD. The test was performed in triplicate

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us